Telness Tech partners with Lebara to Launch New Mobile Operator in Nigeria
Telness Tech, a leading telecom technology provider, is partnering with VAS2Nets and Lebara to launch a new Mobile Virtual Network Operator (MVNO) in Nigeria. The initiative will introduce a telecom service aimed at the rapidly growing telecommunications market in Nigeria. The operator will be powered by Telness Tech industry leading software and customer experience, while bringing Lebara, an internationally recognized telecom brand – to an entirely new region and expansive market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241118892327/en/
from the left; Jonas Cedenwing (Founder CTO, Telness Tech), Teniola Stuffman (Group Executive Director Business Development VAS2Nets), Martina Klingvall (Founder, CEO Telness Tech) (Photo: Business Wire)
In this ambitious partnership, several international telecom companies have joined forces to make this venture possible.
Lebara is one of world’s most recognized MVNOs with direct operations in five European markets, and brand licenses in further five countries - now including Nigeria. Telness Tech’s fully automated platform will streamline, automate the new operator, enabling industry leading customer experience. Processcom will also play a key role, providing the mobile core infrastructure necessary for the network’s functionality. With Vas2Nets as the leading partner, coordinating all international companies in this joint endeavor.
Martina Klingvall, CEO and Founder of Telness Tech, expressed excitement about the collaboration: "This international partnership allows us to bring our cutting-edge telecom technology to Nigeria and is an important step in Telness Tech’s rapid international expansion, following our recent entry into the U.S. market. To enable such a massively recognized brand as Lebara to enter yet another market, combined with our advanced technology and VAS2Nets local expertise - will bring a world class service that to Nigeria’s digital population."
The multi-million-dollar agreement spans several years and includes the launch of both prepaid and postpaid mobile services, with future for PBX solutions. Telness Tech will provide the critical OSS and BSS platforms, ensuring smooth customer management and operations. VAS2Nets, the lead partner, will spearhead the launch of this new operator, which aims to be one of the first new mobile operators to go live in Nigeria.
Teniola Stuffman, Group Executive Director of Business Development at Vas2Nets, highlighted the importance of the collaboration:
"This project enables us to offer Nigerians a high-quality, affordable mobile service through the combined expertise of VAS2Nets, Telness Tech, and Lebara and Processcom. Enabling us to deliver one of the first new mobile operators in Nigeria in years, and with the best technology and offerings on top of that. Rest assured, we’re very proud to lead this joint endeavor”
Daniel Upson, Director of Partnerships at Lebara, comments: “I’m extremely excited about combining all of these capabilities together, between our brand, Telness Tech’s technology and VAS2Nets local expertise, I believe we will deliver a truly world class experience for mobile consumers in Nigeria.”
About Telness Tech
Telness Tech is international software company behind the highest-rated digital mobile operator in Europe, Telness, (4.9/5 on Trustpilot) and was originally founded in 2016. Telness Tech enables cloud-based mobile operators (MVNOs) and other telecommunications companies to launch fully digital user-centric solutions that maximize customer satisfaction and minimize costs through full automation
About VAS2Nets:
Vas2Nets is a technology solutions provider in Nigeria, focused on delivering high-quality telecom services that cater to the growing digital economy in West Africa. Providing a one-stop shop, to individual and business customers, to meet all their mobile digital services and digital banking requirements. VAS2Nets leverages its cutting-edge technology, expertise, licenses and relationships to deliver innovative mobile and digital solutions.
About Lebara:
Lebara is a leading international telecommunications brand known for providing affordable, reliable mobile services to diverse communities around the world. Since its inception, Lebara has grown to serve millions of customers across multiple countries, including the UK, Denmark, the Netherlands, France, and Germany. Through strategic brand licensing partnerships, Lebara is expanding into emerging markets, aiming to bridge the digital divide and connect people globally.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118892327/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
Cessna Grand Caravan EX to Feature New Executive Interior Options, Expanding Opportunities for Elevated Missions15.7.2025 18:05:00 CEST | Press release
The legendary Cessna Grand Caravan EX will now feature three new executive interior schemes for customers to select when designing their aircraft cabin. The Lunar, Obsidian and Saddle Sport interiors join the existing Canyon and Savanna schemes, providing a broader range of standard choices. The new interior options are available to customers starting this month and allow them to further tailor the interior of their aircraft based on their personal preference or mission. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715021096/en/ Cessna Grand Caravan EX to feature new executive interior options, expanding opportunities for elevated missions (Photo Credit: Textron Aviation) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. Premium versions of each of the new interiors are also available, featuring quilted seat stitching and plush carpet, providing an elev
7 Million Tokens Sells Out in less than One Hour—$MBG Token Pre-Sale Shatters Expectations15.7.2025 17:27:00 CEST | Press release
MultiBank Group, the world’s largest and most regulated financial derivatives institution, has set a new benchmark in digital asset launches. The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250715055611/en/ The Group’s $MBG Token Pre-Sale sold out in less than one hour with all 7 million tokens fully subscribed across MultiBank.io and Uniswap. Commenting on the success of the Pre-Sale, Naser Taher, Founder and Chairman of MultiBank Group, said: “The sell-out of our initial $MBG Token offering in less than one hour is a decisive validation of our vision. In a market saturated with speculation, the response we received confirms that institutional-grade transparency, regulatory integrity, and asset-backed value are what investors are now demanding. $MBG is here for the long term, reflecting t
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test15.7.2025 17:01:00 CEST | Press release
Study addressing feasibility of using multi-cancer detection tests in future trials aims to enroll up to 24,000 participantsShield MCD reviewed by FDA as part of NCI’s investigational device exemption (IDE) Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging multi-cancer detection (MCD) technology. Guardant’s Shield™ MCD test was selected for use in the four-year study, which aims to enroll up to 24,000 patients and evaluate the use of MCD tests—blood tests that can screen for several types of cancer simultaneously—in future randomized controlled trials. Guardant’s Shield MCD test was chosen for the study based on the overall performance of its Shield platform in detecting 10 cancer types, including lung, breast, colorectal, prostate, bladder, ovarian, pancreatic, esophageal, liver and gastric. The data were presented at the 2025 American
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom